PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC ; volume:73 ; number:12 ; day:3 ; month:10 ; year:2024 ; pages:1-13 ; date:12.2024
Cancer immunology immunotherapy ; 73, Heft 12 (3.10.2024), 1-13, 12.2024
- Creator
-
Sun, Xiaoyu
Gui, Yaoqi
Yang, Tai
Chen, Lingbing
Zhang, Yi
Yan, Ling
Chen, Weixian
Wang, Bo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-024-03833-z
- URN
-
urn:nbn:de:101:1-2502040908571.332216007414
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-15T07:28:05+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sun, Xiaoyu
- Gui, Yaoqi
- Yang, Tai
- Chen, Lingbing
- Zhang, Yi
- Yan, Ling
- Chen, Weixian
- Wang, Bo
- SpringerLink (Online service)
Other Objects (12)
Patients with COVID-19: in the dark-NETs of neutrophils
Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs)
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
HccB!
"HccB
HccB
Patients with COVID-19: in the dark-NETs of neutrophils
Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs)
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
HccB!
"HccB
HccB
Patients with COVID-19: in the dark-NETs of neutrophils
Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs)
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
HccB!
"HccB